{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-24-077361","form_type":"8-K","ticker":"ABVC","cik":"0001173313","company_name":"ABVC BIOPHARMA, INC.","filed_at":"2024-09-10T23:59:59+00:00","discovered_at":"2026-05-14T18:03:12.336811+00:00","generated_at":"2026-05-31T05:34:17.942279+00:00","sec_items":["8.01"],"event_type":"regulatory","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"ABVC Biopharma regains compliance with Nasdaq Shareholder Approval Rules","bullets":["Received Nasdaq notification on Sept 6, 2024 confirming compliance with Listing Rules 5635(a)(1) and 5635(a)(2).","Compliance based on Board Resolution dated May 16, 2024.","Regained compliance for continued listing on Nasdaq Capital Market."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-24-077361","json":"https://secwatch.observer/filing/0001213900-24-077361.json","markdown":"https://secwatch.observer/filing/0001213900-24-077361.md","text":"https://secwatch.observer/filing/0001213900-24-077361.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1173313/000121390024077361/0001213900-24-077361-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1173313/000121390024077361/ea0214114-8k_abvcbio.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T05:34:17.942279+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}